Vident Advisory’s Idexx Laboratories IDXX Stock Holding History

Vident Advisory's IDXX Position: Q2 2026 in Review

Vident Advisory increased its Idexx Laboratories (IDXX) stake by 7.3% in Q2 2026, buying an estimated $436K and bringing the position to 11,455 shares worth $6.03M. The position accounts for 0.04% of the portfolio, ranked #347.

Vident Advisory first reported a position in IDXX in Q3 2023 and has held it in 12 quarters since. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

• Vident Advisory held 11,455 shares of Idexx Laboratories worth $6.03M as of Q2 2026.
• Vident Advisory bought 778 Idexx Laboratories shares in Q2 2026, an estimated $436K.
• Idexx Laboratories made up 0.04% of Vident Advisory's portfolio in Q2 2026, its #347 holding.
• Vident Advisory first reported a position in Idexx Laboratories in Q3 2023 and has held it in 12 quarters since.
• 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.